Ajax-Loading

Johnson & Johnson - Enterprise Value To Ebitda Ratio

Johnson & Johnson's Fiscal Year is From January To December.

The item "Enterprise-Value-To-Ebitda-Ratio" stands at 11.63 as of 09/30/2025.

As of the end of Johnson & Johnson's third quarter, the item "Enterprise Value To Ebitda Ratio" stands at 11.63. This represents an increase of 5.64 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -23.03 percent compared to the value the year prior.
The 1 year change in percent is -23.03.
The 3 year change in percent is -1.99.

The Serie's long term average value is 13.71. It's latest available value, on 09/30/2025, is 15.14 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is +5.64%.
The Serie's change in percent from it's maximum value, on 06/30/2023, to it's latest available value, on 09/30/2025, is -28.71%.

Enterprise Value To Ebitda Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Enterprise Value To Ebitda Ratio905,699,262,464.00
LogoAbbVie Inc - Enterprise Value To Ebitda Ratio399,570,305,024.00
LogoRoche Holding AG - Enterprise Value To Ebitda Ratio317,433,206,677.55
LogoAstraZeneca PLC - Enterprise Value To Ebitda Ratio280,205,508,085.11
LogoNovartis AG - Enterprise Value To Ebitda Ratio255,096,620,580.91